Quercetin PK/PD Study in Healthy Adults and Patients With Hypercoagulable States
Status:
Completed
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
The goal of this study is to evaluate how much quercetin or isoquercetin is absorbed after a
single dose and evaluate for pharmacokinetic inhibition of protein disulfide isomerase.
Pharmacodynamic studies will also be performed in an additional cohort of 10 patients with
evidence of antiphospholipid antibodies